Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-Controlled, Multicenter, Double-Blind, Randomized Trial of Pegylated Interferon Plus Ribavirin With or Without CTS-1027 in HCV Null-Responders

NCT01273064 is registered in ClinicalTrials.gov with Conatus Pharmaceuticals Inc. as lead sponsor.

NCT NCT01273064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01273064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-Controlled, Multicenter, Double-Blind, Randomized Trial of Pegylated Interferon Plus Ribavirin With or Without CTS-1027 in HCV Null-Responders
Lead sponsor
Conatus Pharmaceuticals Inc.
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2011
Completion date
October 31, 2011
Enrollment
114 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c